Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuv...

por Zhou, Sha, Zhao, Lei, Liang, Zhaohui, Liu, Songran, Li, Yong, Liu, Shiliang, Yang, Hong, Liu, Mengzhong, Xi, Mian
Publicado 2019

Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients

por Zhang, Linjie, Deng, Yuxiang, Liu, Songran, Zhang, Weili, Hong, Zhigang, Lu, Zhenhai, Pan, Zhizhong, Wu, Xiaojun, Peng, Jianhong
Publicado 2023

Association of Sialic Acid–Binding Immunoglobulin-Like Lectin 15 With Phenotypes in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Chemoradiotherapy

por Zhou, Sha, Wang, Yuting, Zhang, Rui, Zeng, Weian, Liu, Shiliang, Liu, Songran, Liu, Mengzhong, Yang, Hong, Xi, Mian
Publicado 2023

RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma

por Qu, Chen, Zhao, Yiying, Feng, Guokai, Chen, Chen, Tao, Yalan, Zhou, Shu, Liu, Songran, Chang, Hui, Zeng, Musheng, Xia, Yunfei
Publicado 2017

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator

por Xu, Yanbo, He, Jiarui, Li, Weihao, Zhang, Weili, Liu, Songran, He, Jiahua, Pan, Zhizhong, Lu, Zhenhai, Peng, Jianhong, Lin, Junzhong
Publicado 2022

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases

por Deng, Yuxiang, Yu, Long, Zhao, Yujie, Peng, Jianhong, Xu, Yanbo, Qin, JiaYi, Xiao, Binyi, Liu, Songran, Li, Mei, Fang, Yujing, Pan, Zhizhong
Publicado 2021

Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospec...

por Liu, SongRan, Qiu, Bo, Chen, LiKun, Wang, Fang, Liang, Ying, Cai, PeiQiang, Zhang, Li, Chen, ZhaoLin, Liu, ShiLiang, Liu, MengZhong, Liu, Hui
Publicado 2015

DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway

por Ding, Shirong, Gao, Ying, Lv, Dongming, Tao, Yalan, Liu, Songran, Chen, Chen, Huang, Zilu, Zheng, Shuohan, Hu, Yujun, Chow, Larry Ka-Yue, Wei, Yinghong, Feng, Ping, Dai, Wei, Wang, Xin, Xia, Yunfei
Publicado 2022

Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma

por Li, Qiwen, Ma, Li, Qiu, Bo, Wen, Yuzhi, Liang, Wenhua, Hu, Wanming, Chen, Naibin, Zhang, Tian, Xu, Shuangbing, Chen, Lingjuan, Guo, Minzhang, Zhao, Yi, Liu, Songran, Guo, Jinyu, Wang, Junye, Wang, Siyu, Wang, Xin, Pang, Qingsong, Long, Hao, Liu, Hui
Publicado 2021